Organon & Co. beat EPS estimates 69% of the time across 16 reported quarters (11 beats, 5 misses), averaging +5.2% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | $0.85 | $0.80 | -5.9% | Miss | |
| Q1 FY26 | $0.82 | $0.66 | -19.5% | Miss | |
| Q3 FY25 | $0.90 | $0.93 | +3.3% | Beat | |
| Q2 FY25 | $0.89 | $0.94 | +5.6% | Beat | |
| Q1 FY25 | $0.83 | $0.95 | +14.5% | Beat | |
| Q4 FY24 | $0.82 | $0.83 | +1.2% | Beat | |
| Q3 FY24 | $0.79 | $0.81 | +2.5% | Beat | |
| Q2 FY24 | $1.01 | $1.03 | +2.0% | Beat | |
| Q1 FY24 | $0.83 | $1.14 | +37.4% | Beat | |
| Q4 FY23 | $0.73 | $0.87 | +19.2% | Beat | |
| Q3 FY23 | $1.04 | $0.78 | -25.0% | Miss | |
| Q2 FY23 | $0.97 | $1.31 | +35.0% | Beat |
Back to OGN overview · OGN holders · OGN KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.